Skip to main content Skip to section navigation Skip to footer
  • Basic Research
  • Biopharma Products
  • Services
  • Resources
  • Support
  • About Enzo
Login or Register
Quick Order
  • Support & Help

Enzo Biochem, Inc Corporate Home

  • Support & Help

Enzo Biochem, Inc Corporate Home

Login or Register
$0.00 0 products

Your Cart

No products in the cart.

Quick Order
  • Basic Research Products
  • Biopharma Products
  • Services
  • Resources
  • Support
  • About Enzo

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Company Profile
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote and Chart
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • IR Calendar
  • Email Alerts
Nov 6, 2023 8:00 am EST
ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE
Oct 30, 2023 4:15 pm EDT
Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
Sep 6, 2023 8:30 am EDT
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
Jul 24, 2023 4:27 pm EDT
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
Jun 14, 2023 7:21 pm EDT
Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results
May 22, 2023 9:20 am EDT
Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale
Apr 24, 2023 4:05 pm EDT
Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders
Mar 21, 2023 9:43 am EDT
Enzo Biochem Reports Second Quarter Fiscal Year 2023 Financial Results
Mar 16, 2023 4:30 pm EDT
Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp
Dec 12, 2022 5:29 pm EST
Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Update
  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 34
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
  • accessibilityAccessibility Statement
Enzo logo
  • Who We Serve
    • Academic Research
    • Biotech & Pharma
    • CROs
    • Diagnostic Manufacturers
  • Our Offering
    • Basic Research Products
    • Biopharma Products
  • Resources
    • Blogs
    • Scientific Literature
    • Application Notes
    • E-Books
    • Webinars
  • Support
    • Your Account
    • Online Support
    • FAQs
    • Programs & Offers
    • Customer Service
    • Technical Support
    • Clinical Lab Results
  • About Enzo
    • Investors
    • Scientists Enabling Scientists
    • Careers
    • Partnering with Us
  • Legal
    • Terms & Conditions
    • Disclaimer
    • Privacy Policy
    • Cookie Policy
    • Cookie Preferences
    • Safe Harbor Statement
    • Intellectual Property
    • Global HIPAA Notice
    • Modern Slavery and Human Trafficking Statement
Follow us: Facebook Instagram LinkedIn X/Twitter
Copyright © 2025 Enzo Biochem Inc.

Welcome to Enzo’s new website, Enzo.com

You’re in the right place!

Enzo’s new website has combined Enzo.com, Enzolifesciences.com, and Axxora.com all in one great site!